𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Smoking and hypertension: risk factors for carotid stenosis

✍ Scribed by H. R. Müller; M. W. Buser


Book ID
104719390
Publisher
Springer
Year
1991
Tongue
English
Weight
592 KB
Volume
238
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

✦ Synopsis


The prevalence of smoking, hypertension and diabetes mellitus was assessed in 221 patients suffering from internal carotid stenosis and compared with the prevalences in two sex- and age-matched control groups composed of subjects having normal Doppler findings and from non-neurological outpatients. Of the subjects with carotid stenosis 27.6% were hypertensive smokers in comparison with 9.5% and 17.2% in the two control groups. The difference of the stenosis cohort from the two control groups was significant (P less than 0.01 and P = 0.016 respectively). There was no statistically significant differences between the occurrence of diabetes and hypertension in non-smokers and patients who smoked. In 394 investigated patients suffering from carotid stenosis or occlusion an obstruction index, based on the Doppler shift frequency, was calculated. This index was lowest in the normotensive smokers [corrected]. It was only insignificantly higher in the hypertensive non-smokers but significantly so in the normotensive smokers. The index was highest in the hypertensive smokers [corrected]. It was concluded that cigarette smoking, especially if associated with hypertension, is a determinant risk factor for carotid stenosis and occlusion.


📜 SIMILAR VOLUMES


Clinical risk factors for portopulmonary
✍ Steven M. Kawut; Michael J. Krowka; James F. Trotter; Kari E. Roberts; Raymond L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

for the Pulmonary Vascular Complications of Liver Disease Study Group Portopulmonary hypertension affects up to 6% of patients with advanced liver disease, but the predictors and biologic mechanism for the development of this complication are unknown. We sought to determine the clinical risk factors